This work expands the pool of NHRs as oncologic biomarkers by showing that three previously undescribed NHRs lose expression in a subset of endometrial tumors – THRB, PPARG, and NR4A1. The previously undescribed connection between these three NHRs and endometrial cancer will be described in turn. The gene discussed is THRB; the disease is endometrial cancer.